A. Thawer

发表

Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual Care

F. Wright, S. Singh, Nicholas Meti, 2021, Journal of patient experience.

Avelumab in unresectable/metastatic, progressive, grade 2-3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials.

J. Hallet, N. Iscoe, C. Law, 2022, European journal of cancer.

Temozolomide in grade III gastroenteropancreatic neuroendocrine neoplasms (G3 GEPNENs): A multicentre retrospective review.

N. Raj, S. Singh, T. Halfdanarson, 2021, The oncologist.

Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process

C. Fox, F. Wright, S. Singh, 2021, Current oncology.

SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience

S. Singh, Nicholas Meti, Janice Stewart, 2021, Current oncology.

Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database

J. Knox, R. Ramjeesingh, T. Abedin, 2022, Liver Cancer International.

Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review

Nitya, A., Emily, 2021 .

Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Socie

D. Metz, A. Sung, M. Soulen, 2020 .

Multi-disciplinary proactive follow-up algorithm for patients with advanced NSCLC receiving afatinib

S. Cheng, P. Cheema, J. Charles Victor, 2018, Supportive Care in Cancer.

CommNETs/NANETS guidelines for the diagnosis and management of patients with Lung Neuroendocrine Tumors: An international collaborative endorsement and update of the 2015 ENETS expert consensus guidelines.

D. Metz, A. Sung, M. Soulen, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Management of anticoagulation in patients with metastatic castration–resistant prostate cancer receiving abiraterone + prednisone

U. Emmenegger, Thomas McFarlane, Samuel Dubinsky, 2019, Supportive Care in Cancer.

Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?

S. Singh, J. Capdevila, D. Ferone, 2021, Current Oncology Reports.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

M. Somerfield, I. Makhoul, A. Eisen, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

E. Baudin, M. Falconi, K. Herrmann, 2020, European Journal of Cancer.

Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma.

G. Bjarnason, J. Raphael, A. Thawer, 2018, Urologic oncology.

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

K. Savage, W. Miller, T. Petrella, 2021, Current oncology.

Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.

N. Raj, S. Singh, T. Halfdanarson, 2019, Journal of Clinical Oncology.

Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments

E. Segelov, A. Thawer, Matthew Anaka, 2023, The oncologist.